Cambridge Research Biochemicals To Provide Monoclonal Antibody Production
Sep 30th 2008Drug InformationBiology
Cambridge Research Biochemicals (CRB), a specialist in the custom production of polyclonal antibodies, is now expanding its antibody offering to include monoclonal antibody production via two new agreements with Babraham Bioscience Technologies (BBT) and Epitomics Inc. CRB and Cambridge-based BBT have formed an alliance that will enable CRB to market custom monoclonal antibody projects (via mouse/rat hybridomas) from BBT.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
